G.P.M. Luyten
Professor Ophthalmology
- Name
- Prof.dr. G.P.M. Luyten
- Telephone
- +31 71 526 6674
- g.p.m.luyten@lumc.nl
Professor, chairman and director of residence program department of Ophthalmology, Leiden University Medical Center (LUMC), Leiden.
More information about G.P.M. Luyten
Professor, chairman and director of residence program department of Ophthalmology, Leiden University Medical Center (LUMC), Leiden.
Ophthalmology
Prof. G.P.M. Luyten was trained as an ophthalmologist with field of interest ocular oncology and refractive surgery. Academic ophthalmic care functions in the chain, where we have to take care of the high-complex care. We want to ensure that patients can receive the best care at the right place and at the right time. This requires good cooperation with the various chain providers, general practitioners, optometrists, ophthalmologists and the rehabilitation organisations to promote the maximum participation of patients in society. It is our role in the strong connection of patient care, education and research always to seek and to strive for innovation and improvement of the eye care, to implement this, to teach this and to transfer to our ophthalmic colleagues so that we can ensure the best ophthalmic care.
Eye oncology
From the clinic Prof. Luyten is directly involved in the diagnosis and treatment of patients with ocular melanoma as a national referral center. The research lines are the (clinical) outcomes, quality of life, evaluation of the treatment of patients with primary and metastatic eye melanoma with the ultimate goal of improving the prognosis and quality of life of these patients. Current lines include setting up a national outpatient clinic for BAP1 tumour predisposition syndrome and research and implementation of image-guided proton irradiation.
Dysphotopia
We see every day more patients who are increasingly suffering from dysphotopia (negative and positive) after a successfully performed cataract surgery (4-18%) and is in many cases not recognized by general ophthalmologists. There is no clear explanation and solution for these problems and complaints. In the context of a European subsidized study with a high-resolution MRI eye model, a statement was explored using raytracing technology. As a national referral center, a lens change is performed in these patients with a success rate of up to 80%.
Regenerative medicine
The combination of top referral clinical care in the field of pediatric ophthalmology and hereditary and non-hereditary retinal diseases and top researchers in the field of gene therapy and stem cell research means that the department will make a strong commitment to this research area. Thanks to the collaborations within and outside the LUMC, both nationally and internationally, this offers great opportunities to reach clinical applications within 10 years that will make big differences.
Academic career
- Student researcher in cell biology genetics (Prof. Galjaard), Erasmus University Rotterdam
- Thesis 16 May 1996: 'Primary and metastatic uveal melanoma: towards a therapeutic approach'
- Inaugural lecture January 15, 2008: 'Learning to look different'
Professor Ophthalmology
- Faculteit Geneeskunde
- Divisie 3
- Oogheelkunde
- Vught, L. van; Beenakker, J.W.M. & Luyten, G.P.M. (2021), Reply to comment on: Distinct differences in anterior chamber configuration and peripheral aberrations in negative dysphotop.
- Roelofsen, C.D.M.; Wierenga, A.P.A.; Duinen, S. van; Verdijk, R.M.; Bleeker, J.; Marinkovic, M.; Luyten, G.P.M. & Jager, M.J. (2020), Five Decades of Enucleations for Uveal Melanoma in One Center: More Tumors with High Risk Factors, No Improvement in Survival over Time, Ocular Oncology and Pathology.
- Souri, Z.; Jochemsen, A.G.; Versluis, M.; Wierenga, A.P.A.; Nemati, F.; Velden, P.A. van der; Kroes, W.G.M.; Verdijk, R.M.; Luyten, G.P.M. & Jager, M.J. (2020), HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma, Cancers 12(12).
- Brouwer, N.J.; Marinkovic, M.; Bleeker, J.C.; Filali, M. el; Stefansson, E.; Luyten, G.P.M. & Jager, M.J. (2020), RETINAL OXIMETRY IS ALTERED IN EYES WITH CHOROIDAL MELANOMA BUT NOT IN EYES WITH CHOROIDAL NEVI, RETINA, The Journal of Retinal and Vitreous Diseases 40(11): 2207-2215.
- Gaurisankar, Z.S.; Rijn, G.A. van; Haasnoot, G.W.; Verhoeven, V.J.M.; Klaver, C.C.W.; Luyten, G.P.M. & Beenakker, J.W.M. (2020), Long-term longitudinal changes in axial length in the Caucasian myopic and hyperopic population with a phakic intraocular lens, Acta Ophthalmologica.
- Houtzagers, L.E.; Wierenga, A.P.A.; Ruys, A.A.M.; Luyten, G.P.M. & Jager, M.J. (2020), Iris Colour and the Risk of Developing Uveal Melanoma, International Journal of Molecular Sciences 21(19).
- Gaurisankar, Z.S.; Rijn, G.A. van; Luyten, G.P.M. & Beenakker, J.W.M. (2020), Differences between Scheimpflug and optical coherence tomography in determining safety distances in eyes with an iris-fixating phakic intraocular lens, Graefe's Archive for Clinical and Experimental Ophthalmology.
- Brouwer, N.J.; Marinkovic, M.; Peters, F.P.; Hulshof, M.C.C.M.; Pieters, B.R.; Keizer, R.J.W. de; Horeweg, N.; Laman, M.S.; Bleeker, J.C.; Duinen, S.G. van; Jager, M.J.; Creutzberg, C.L. & Luyten, G.P.M. (2020), Management of conjunctival melanoma with local excision and adjuvant brachytherapy, Eye.
- Dogrusoz, M.; Brouwer, N.J.; Geus, S.J.R. de; Ly, L.V.; Bohringer, S.; Duinen, S.G. van; Kroes, W.G.M.; Velden, P.A. van der; Haasnoot, G.W.; Marinkovic, M.; Luyten, G.P.M.; Kivela, T.T. & Jager, M.J. (2020), Prognostic Factors Five Years After Enucleation for Uveal Melanoma, Investigative Ophthalmology & Visual Science 61(3).
- Rola, A.C.; Taktak, A.; Eleuteri, A.; Kalirai, H.; Heimann, H.; Hussain, R.; Bonnett, L.J.; Hill, C.J.; Traynor, M.; Jager, M.J.; Marinkovic, M.; Luyten, G.P.M.; Dogrusoz, M.; Kilic, E.; Klein, A. de; Smit, K.; Poppelen, N.M. van; Damato, B.E.; Afshar, A.; Guthoff, R.F.; Scheef, B.O.; Kakkassery, V.; Saakyan, S.; Tsygankov, A.; Mosci, C.; Ligorio, P.; Viaggi, S.; Guin, C.H.D. le; Bornfeld, N.; Bechrakis, N.E. & Coupland, S.E. (2020), Multicenter External Validation of the Liverpool Uveal Melanoma Prognosticator Online: An OOG Collaborative Study, Cancers 12(2).
- Rijn, G.A. van; Wijnen, C.J.F.; Dooren, B.T.H. van; Cheng, Y.Y.Y.; Beenakker, J.W.M. & Luyten, G.P.M. (2020), Improved Interchangeability with Different Corneal Specular Microscopes for Quantitative Endothelial Cell Analysis, CLINICAL OPHTHALMOLOGY 14: 61-70.
- Rijn, G. van; Gaurisankar, Z.S.; Ilgenfritz, A.P.; Lima, J.E.E.; Haasnoot, G.W.; Beenakker, J.W.M.; Cheng, Y.Y.Y. & Luyten, G.P.M. (2020), Middle- and long-term results after iris-fixated phakic intraocular lens implantation in myopic and hyperopic patients: a meta-analysis, Journal of Cataract and Refractive Surgery 46(1): 125-137.
- Fonk, L.G.; Ferreira, T.A.; Webb, A.G.; Luyten, G.P.M. & Beenakker, J.W.M. (2020), The Economic Value of MR-Imaging for Uveal Melanoma, CLINICAL OPHTHALMOLOGY 14: 1135-1143.
- Gaurisankar, Z.S.; Rijn, G.A. van; Lima, J.E.E.; Ilgenfritz, A.P.; Cheng, Y.; Haasnoot, G.W.; Luyten, G.P.M. & Beenakker, J.W.M. (2019), Correlations between ocular biometrics and refractive error: A systematic review and meta-analysis, Acta Ophthalmologica 97(8): 735-743.
- Gaurisankar, Z.S.; Rijn, G.A. van; Luyten, G.P.M. & Berg, T.J.T.P. van den (2019), Straylight As The Result Of Refractive Correction, Clinical Ophthalmology 13: 2195-2201.
- Wierenga, A.P.A.; Cao, J.F.; Mouthaan, H.; Weeghel, C. van; Verdijk, R.M.; Duinen, S.G. van; Kroes, W.G.M.; Dogrusoz, M.; Marinkovic, M.; Burg, S.S.H. van der; Luyten, G.P.M. & Jager, M.J. (2019), Aqueous Humor Biomarkers Identify Three Prognostic Groups in Uveal Melanoma, Investigative Ophthalmology & Visual Science 60(14): 4740-4747.
- Dogrusoz, M.; Trasel, A.R.; Cao, J.F.; Colak, S.; Pelt, S.I. van; Kroes, W.G.M.; Teunisse, A.E.A.S.; Alsafadi, S.; Duinen, S.G. van; Luyten, G.P.M.; Velden, P.A. van der; Amaro, A.; Pfeffer, U.; Jochemsen, A.G. & Jager, M.J. (2019), Differential Expression of DNA Repair Genes in Prognostically-Favorable versus Unfavorable Uveal Melanoma, Cancers 11(8).
- Weeghel, C. van; Wierenga, A.P.A.; Versluis, M.; Hall, T. van; Velden, P.A. van der; Kroes, W.G.M.; Pfeffer, U.; Luyten, G.P.M. & Jager, M.J. (2019), Do GNAQ and GNA11 Differentially Affect Inflammation and HLA Expression in Uveal Melanoma?, Cancers 11(8).
- Chau, C.; Doorn, R. van; Poppelen, N.M. van; Stoep, N. van der; Mensenkamp, A.R.; Sijmons, R.H.; Paassen, B.W. van; Ouweland, A.M.W. van den; Naus, N.C.; Hout, A.H. van der; Potjer, T.P.; Bleeker, F.E.; Wevers, M.R.; Hest, L.P. van; Jongmans, M.C.J.; Marinkovic, M.; Bleeker, J.C.; Jager, M.J.; Luyten, G.P.M. & Nielsen, M. (2019), Families with BAP1-Tumor Predisposition Syndrome in The Netherlands: Path to Identification and a Proposal for Genetic Screening Guidelines, Cancers 11(8).
- Souri, Z.; Wierenga, A.P.A.; Weeghel, C. van; Velden, P.A. van der; Kroes, W.G.M.; Luyten, G.P.M.; Burg, S.H. van der; Jochemsen, A.G. & Jager, M.J. (2019), Loss of BAP1 Is Associated with Upregulation of the NFkB Pathway and Increased HLA Class I Expression in Uveal Melanoma, Cancers 11(8).
- Brouwer, N.J.; Marinkovic, M.; Luyten, G.P.M.; Shields, C.L. & Jager, M.J. (2019), Pigmentation of conjunctival melanoma recurrences and outcome, Graefe's Archive for Clinical and Experimental Ophthalmology 257(8): 1783-1788.
- Wierenga, A.P.A.; Gezgin, G.; Beelen, E. van; Eikmans, M.; Spruyt-Gerritse, M.; Brouwer, N.J.; Versluis, M.; Verdijk, R.M.; Duinen, S.G. van; Marinkovic, M.; Luyten, G.P.M. & Jager, M.J. (2019), Soluble HLA in the Aqueous Humour of Uveal Melanoma Is Associated with Unfavourable Tumour Characteristics, Cancers 11(8).
- Jaarsma-Coes, M.G.; Ferreira, T.A.; Luyten, G.P.M. & Beenakker, J.W.M. (2019), Reaction on "Ocular ultrasound versus MRI in the detection of extrascleral extension in a patient with choroidal melanoma", BMC Ophthalmology 19(1).
- Brouwer, N.J.; Wierenga, A.P.A.; Gezgin, G.; Marinkovic, M.; Luyten, G.P.M.; Kroes, W.G.M.; Versluis, M.; Velden, P.A. van der; Verdijk, R.M. & Jager, M.J. (2019), Ischemia Is Related to Tumour Genetics in Uveal Melanoma, Cancers 11(7).
- Brouwer, N.J.; Gezgin, G.; Wierenga, A.P.A.; Bronkhorst, I.H.G.; Marinkovic, M.; Luyten, G.P.M.; Versluis, M.; Kroes, W.G.M.; Velden, P.A. van der; Verdijk, R.M. & Jager, M.J. (2019), Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution, Cancers 11(7).
- Brouwer, N.J.; Marinkovic, M.; Luyten, G.P.M.; Shields, C.L. & Jager, M.J. (2019), Lack of tumour pigmentation in conjunctival melanoma is associated with light iris colour and worse prognosis, British Journal of Ophthalmology 103(3): 332-337.
- Mohabati, D.; Rijssen, T.J. van; Dijk, E.H.C. van; Luyten, G.R.P.M.; Missotten, T.O.; Hoyng, C.B.; Yzer, S. & Boon, C.J.F. (2018), Clinical characteristics and long-term visual outcome of severe phenotypes of chronic central serous chorioretinopathy, Clinical Ophthalmology 12: 1061-1070.
- Walpole, S.; Pritchard, A.L.; Cebulla, C.M.; Pilarski, R.; Stautberg, M.; Davidorf, F.H.; Fouchardiere, A. de la; Cabaret, O.; Golmard, L.; Stoppa-Lyonnet, D.; Garfield, E.; Njauw, C.N.; Cheung, M.; Turunen, J.A.; Repo, P.; Jarvinen, R.S.; Doorn, R. van; Jager, M.J.; Luyten, G.P.M.; Marinkovic, M.; Chau, C.; Potrony, M.; Hoiom, V.; Helgadottir, H.; Pastorino, L.; Bruno, W.; Andreotti, V.; Dalmasso, B.; Ciccarese, G.; Queirolo, P.; Mastracci, L.; Wadt, K.; Kiilgaard, J.F.; Speicher, M.R.; Poppelen, N. van; Kilic, E.; Al-Jamal, R.T.; Dianzani, I.; Betti, M.; Bergmann, C.; Santagata, S.; Dahiya, S.; Taibjee, S.; Burke, J.; Poplawski, N.; O'Shea, S.J.; Newton-Bishop, J.; Adlard, J.; Adams, D.J.; Lane, A.M.; Kim, I.; Klebe, S.; Racher, H.; Harbour, J.W.; Nickerson, M.L.; Murali, R.; Palmer, J.M.; Howlie, M.; Symmons, J.; Hamilton, H.; Warrier, S.; Glasson, W.; Johansson, P.; Robles-Espinoza, C.D.; Ossio, R.; Klein, A. de; Puig, S.; Ghiorzo, P.; Nielsen, M.; Kivela, T.T.; Tsao, H.; Testa, J.R.; Gerami, P.; Stern, M.H.; Bressac-de Paillerets, B.; Abdel-Rahman, M.H. & Hayward, N.K. (2018), Comprehensive Study of the Clinical Phenotype of Germline BAP1 Variant-Carrying Families Worldwide, JNCI: Journal of the National Cancer Institute 110(12): 1328-1341.
- Brouwer, N.J.; Marinkovic, M.; Jochems, A.; Kapiteijn, E.W.; Duinen, S.G. van; Haeseker, B.I.; Jager, M.J. & Luyten, G.P.M. (2018), Conjunctival Metastasis of a Cutaneous Melanoma, Ocular Oncology and Pathology 4(2): 107-111.
- Ferreira, T.A.; Saraiva, P.; Genders, S.W.; Buchem, M.V.; Luyten, G.P.M. & Beenakker, J.W. (2018), CT and MR imaging of orbital inflammation, Neuroradiology 60(12): 1253-1266.
- Lange, M.J. de; Nell, R.J.; Lalai, R.N.; Versluis, M.; Jordanova, E.S.; Luyten, G.P.M.; Jager, M.J.; Burg, S.H. van der; Zoutman, W.H.; Hall, T. van & Velden, P.A. van der (2018), Digital PCR-Based T-cell Quantification-Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma, Molecular Cancer Research 16(12): 1902-1911.
- Beek, J.G.M. van; Buitendijk, G.H.S.; Timman, R.; Muller, K.; Luyten, G.P.M.; Paridaens, D.; Naus, N.C. & Kilic, E. (2018), Quality of life: fractionated stereotactic radiotherapy versus enucleation treatment in uveal melanoma patients, Acta Ophthalmologica 96(8): 841-848.
- Brouwer, N.J.; Genders, S.W.; Marinkovic, M.; Duinen, S.G. van; Jager, M.J. & Luyten, G.P.M. (2018), Two Late Recurrences of Conjunctival Melanoma, Ocular Oncology and Pathology 5(4): 262-266.
- Dijk, E.H.C. van; Kruit, W.H.J.; Jager, M.J.; Luyten, G.P.M.; Vingerling, J.R. & Boon, C.J.F. (2018), Pimasertib-associated ophthalmological adverse events, Acta Ophthalmologica 96(7): 712-718.
- Brouwer, N.J.; Marinkovic, M.; Duinen, S.G. van; Bleeker, J.C.; Jager, M.J. & Luyten, G.P.M. (2018), Treatment of conjunctival melanoma in a Dutch referral centre, British Journal of Ophthalmology 102(9): 1277-1282.
- Marinkovic, M.; Horeweg, N.; Laman, M.S.; Bleeker, J.C.; Ketelaars, M.; Peters, F.P.; Luyten, G.P.M. & Creutzberg, C.L. (2018), Ruthenium-106 brachytherapy for iris and iridociliary melanomas, British Journal of Ophthalmology 102(8): 1154-1159.
- Wouters, M.W.; Michielin, O.; Bastiaannet, E.; Beishon, M.; Catalano, O.; Marmol, V.; Delgado-Bolton, R.; Dendale, R.; Trill, M.D.; Ferrari, A.; Forsea, A.M.; Kreckel, H.; Lovey, J.; Luyten, G.; Massi, D.; Mohr, P.; Oberst, S.; Pereira, P.; Prata, J.P.P.; Rutkowski, P.; Saarto, T.; Sheth, S.; Spurrier-Bernard, G.; Vuoristo, M.S.; Costa, A. & Naredi, P. (2018), ECCO essential requirements for quality cancer care: Melanoma, Critical Reviews in Oncology/Hematology 122: 164-178.
- Brouwer, N.J.; Luyten, G.P.M.; Duinen, S.G. van; Jager, M.J. & Marinkovic, M. (2017), Multiple Pigmented Conjunctival Lesions following Intravitreal Injections in a Patient with Uveal Melanoma, Ocular Oncology and Pathology 3(2): 113-116.
- Gezgin, G.; Dogrusoz, M.; Essen, T.H. van; Kroes, W.G.M.; Luyten, G.P.M.; Velden, P.A. van der; Walter, V.; Verdijk, R.M.; Hall, T. van; Burg, S.H. van der & Jager, M.J. (2017), Genetic evolution of uveal melanoma guides the development of an inflammatory microenvironment, Cancer Immunology, Immunotherapy 66(7): 903-912.
- Gezgin, G.; Luk, S.J.; Cao, J.F.; Dogrusoz, M.; Steen, D.M. van der; Hagedoorn, R.S.; Krijgsman, D.; Velden, P.A. van der; Field, M.G.; Luyten, G.P.M.; Szuhai, K.; Harbour, J.W.; Jordanova, E.S.; Heemskerk, M.H.M. & Jager, M.J. (2017), PRAME as a Potential Target for Immunotherapy in Metastatic Uveal Melanoma, JAMA Ophthalmology 135(6).
- Fonk, L.G.; Verstegen, M.; Teeuwisse, W.; Ferreira, T.; Furth, W. van; Pereira, A.; Webb, A.; Notting, I.; Luyten, G. & Beenakker, J.W. (2017), MR imaging of the optic nerve and chiasm at 7 Tesla improves lesion detection for Neuro-Ophthalmic conditions compared to conventional clinical field strengths, Acta Ophthalmologica 95: 27-27.
- Vught, L. van; Hervella, L.; Tabernero, J.; Shamonin, D.P.; Webb, A.G.; Artal, P.; Luyten, G.P.M. & Beenakker, J.W.M. (2017), Personalized eye-models for optical assessment of ocular conditions, Acta Ophthalmologica 95: 8-9.
- Beenakker, J.W.M.; Vught, L. van; Meel, R. de; Burakiewicz, J.; Genders, S.; Jager, M.; Luyten, G.P.M.; Verschuuren, J.J.G.M.; Kan, H.E. & Notting, I.C. (2017), Quantitative MRI of extra-ocular muscles in the clinical evaluation of systemic diseases, Acta Ophthalmologica 95: 12-13.
- Luyten, G.; Marinkovic, M.; Sommers, L.; Horeweg, N.; Fiocco, M.; Bleeker, J. & Creutzberg, C.L. (2017), Ruthenium-106 brachytherapy for uveal melanoma without transpupillary thermotherapy: similar efficacy with improved visual outcome, Acta Ophthalmologica 95: 15-15.
- Jong, Y. de; Haverkort, M.E.; Sorge, A.J. van; Jansen, C.; Luyten, G.P.M. & Joosse, M. (2017), A translucent vascularised iris granuloma in a patient with secondary syphilis, Lancet Infectious Diseases 17(3): 255-256.
- Dogrusoz, M.; Bagger, M.; Duinen, S.G. van; Kroes, W.G.; Ruivenkamp, C.A.L.; Bohringer, S.; Andersen, K.K.; Luyten, G.P.M.; Kiilgaard, J.F. & Jager, M.J. (2017), The Prognostic Value of AJCC Staging in Uveal Melanoma Is Enhanced by Adding Chromosome 3 and 8q Status, Investigative Ophthalmology & Visual Science 58(2).
- Leede, E.M. de; Burgmans, M.C.; Kapiteijn, E.; Luyten, G.P.M.; Jager, M.J.; Tijl, F.G.J.; Hartgrink, H.H.; Grunhagen, D.J.; Rothbarth, J.; Veldea, C.J.H. van de; Verhoef, C. & Vahrmeijer, A.L. (2016), Isolated (hypoxic) hepatic perfusion with high-dose chemotherapy in patients with unresectable liver metastases of uveal melanoma: results from two experienced centres, Melanoma Research 26(6): 588-594.
- Kalirai, H.; Shahidipour, H.; Moss, D.; Coupland, S.E. & Luyten, G.P.M. (2016), Use of the Chick Embryo Model in Uveal Melanoma (vol 1, pg 133, 2015), Ocular Oncology and Pathology 2(1): 59-59.
- Tideman, J.W.L.; Snabel, M.C.C.; Tedja, M.S.; Rijn, G.A. van; Wong, K.T.; Kuijpers, R.W.A.M.; Vingerling, J.R.; Hofman, A.; Buitendijk, G.H.S.; Keunen, J.E.E.; Boon, C.J.F.; Geerards, A.J.M.; Luyten, G.P.M.; Verhoeven, V.J.M. & Klaver, C.C.W. (2016), Association of Axial Length With Risk of Uncorrectable Visual Impairment for Europeans With Myopia, JAMA Ophthalmology 134(12): 1355-1363.
- Marinkovic M., Horeweg N., Fiocco M., Peters F.P., Sommers L.W., Laman M.S., Bleeker J.C., Ketelaars M., Luyten G.P.M. & Creutzberg C.L. (2016), Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome, EUROPEAN JOURNAL OF CANCER 68: 106-113.
- Marinkovic, M.; Horeweg, N.; Fiocco, M.; Peters, F.P.; Sommers, L.W.; Laman, M.S.; Bleeker, J.C.; Ketelaars, M.; Luyten, G.P.M. & Creutzberg, C.L. (2016), Ruthenium-106 brachytherapy for choroidal melanoma without transpupillary thermotherapy: Similar efficacy with improved visual outcome, European Journal of Cancer 68: 106-113.
- Essen, T.H. van; Pelt, S.I. van; Bronkhorst, I.H.G.; Versluis, M.; Nemati, F.; Laurent, C.; Luyten, G.P.M.; Hall, T. van; Elsen, P.J. van den; Decaudin, D. & Jager, M.J. (2016), Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes, PLoS ONE 11(10).
- Dogrusoz, M.; Bagger, M.; Duinen, S.G. van; Kroes, W.G.M.; Bohringer, S.; Luyten, G.P.M.; Kiilgaard, J.F. & Jager, M.J. (2016), AJCC Staging and Chromosome 3 and 8 status complement each other regarding prognostic value in Uveal Melanoma, Investigative Ophthalmology & Visual Science 57(12).
- Verhoeven, V.J.M.; Snabel, M.C.C.; Rijn, G.A. van; Buitendijk, G.H.S.; Vvong, K.T.; Keunen, J.E.E.; Boon, C.J.F.; Geerards, A.J.M.; Luyten, G.P.M. & Klaver, C.C.W. (2016), Axial length and visual function in high myopia, Investigative Ophthalmology & Visual Science 57(12).
- Beenakker, J.W.; Ferreira, T.; Soemarwoto, K.; Genders, S.; Teeuwisse, W.; Webb, A. & Luyten, G.P.M. (2016), Clinical evaluation of ultra high field MRI for three-dimensional visualization of tumour size in uveal melanoma patients, with direct relevance to treatment planning, Investigative Ophthalmology & Visual Science 57(12).
- Gezgin, G.; Luk, S.J.; Cao, J.F.; Dogrusoz, M.; Krijgsman, D.; Velden, P.A. van der; Luyten, G.P.M.; Harbour, J.W.; Jordanova, E.S.; Heemskerk, M.H.M. & Jager, M.J. (2016), PRAME: a potential target for immunotherapy in uveal melanoma, Investigative Ophthalmology & Visual Science 57(12).
- Beenakker, J.W.M.; Ferreira, T.A.; Soemarwoto, K.P.; Genders, S.W.; Teeuwisse, W.M.; Webb, A.G. & Luyten, G.P.M. (2016), Clinical evaluation of ultra-high-field MRI for three-dimensional visualisation of tumour size in uveal melanoma patients, with direct relevance to treatment planning, Magnetic Resonance Materials in Physics, Biology and Medicine 29(3): 571-577.
- Jongman, H.P.; Marinkovic, M.; Notting, I.; Koetsier, L.; Swart, W.; Schalij-Delfos, N.E.; Bleeker, J.; Jager, M.J. & Luyten, G.P.M. (2016), Donor sclera-wrapped acrylic orbital implants following enucleation: experience in 179 patients in the Netherlands, Acta Ophthalmologica 94(3): 253-256.
- Dijk, E.H.C. van; Duits, D.E.M.; Versluis, M.; Luyten, G.P.M.; Bergen, A.A.B.; Kapiteijn, E.W.; Lange, M.J. de; Boon, C.J.F. & Velden, P.A. van der (2016), Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients, Medicine 95(18).
- Essen, T.H. van; Zijl, L. van; Possemiers, T.; Mulder, A.A.; Zwart, S.J.; Chou, C.H.; Lin, C.C.; Lai, H.J.; Luyten, G.P.M.; Tassignon, M.J.; Zakaria, N.; Ghalbzouri, A. el & Jager, M.J. (2016), Biocompatibility of a fish scale-derived artificial cornea: Cytotoxicity, cellular adhesion and phenotype, and in vivo immunogenicity, Biomaterials 81: 36-45.
- Nielsen, M.; Dogrusoz, M.; Bleeker, J.C.; Kroes, W.G.; Asperen, C.J. van; Marinkovic, M.; Luyten, G.P. & Jager, M.J. (2015), The genetic basis of uveal melanoma (vol 38, pg 516, 2015), Journal Fran�ais D'Ophtalmologie 38(10): 1021-1021.
- Kalirai, H.; Shahidipour, H.; Coupland, S.E. & Luyten, G.P.M. (2015), Use of the Chick Embryo Model in Uveal Melanoma, Ocular Oncology and Pathology 1(3): 133-140.
- Lange, M.J. de; Pelt, S.I. van; Versluis, M.; Jordanova, E.S.; Kroes, W.G.M.; Ruivenkamp, C.; Burg, S.H. van der; Luyten, G.P.M.; Hall, T. van; Jager, M.J. & Velden, P.A. van der (2015), Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma, Oncotarget 6(35): 37824-37835.
- Jager, M.J.; Krijgsman, D.; Luyten, G.P.M.; Luk, S.J.; Velden, P. van der & Heemskerk, M.H.M. (2015), Selecting uveal melanoma for PRAME-TCR T cell immunotherapy, Acta Ophthalmologica 93.
- Dogrusoz, M.; Kroes, W.G.M.; Duinen, S.G. van; Creutzberg, C.L.; Versluis, M.; Bleeker, J.C.; Marinkovic, M.; Luyten, G.P.M. & Jager, M.J. (2015), Radiation Treatment Affects Chromosome Testing in Uveal Melanoma, Investigative Ophthalmology & Visual Science 56(10): 5956-5964.
- Dijk, E.H.C. van; Herpen, C.M.L. van; Marinkovic, M.; Haanen, J.B.A.G.; Amundson, D.; Luyten, G.P.M.; Jager, M.J.; Kapiteijn, E.H.W.; Keunen, J.E.E.; Adamus, G. & Boon, C.J.F. (2015), Serous Retinopathy Associated with Mitogen-Activated Protein Kinase Kinase Inhibition (Binimetinib) for Metastatic Cutaneous and Uveal Melanoma, Ophthalmology: Journal of The American Academy of Ophthalmology 122(9): 1907-1916.
- Lange, M.J. de; Razzaq, L.; Versluis, M.; Verlinde, S.; Dogrusoz, M.; Bohringer, S.; Marinkovic, M.; Luyten, G.P.M.; Keizer, R.J.W. de; Gruijl, F.R. de; Jager, M.J. & Velden, P.A. van der (2015), Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism, PLoS ONE 10(9).
- Lange, M.J. de; Razzaq, L.; Versluis, M.; Verlinde, S.; Dogrusoz, M.; Bohringer, S.; Marinkovic, M.; Luyten, G.P.M.; Keizer, R.J.W. de; Gruijl, F.R. de; Jager, M.J. & Velden, P.A. van der (2015), Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism, PLoS ONE 10(9).
- Rodenburg-Vandenbussche, S.; Pieterse, A.H.; Kroonenberg, P.M.; Scholl, I.; Weijden, T. van der; Luyten, G.P.M.; Kruitwagen, R.F.P.M.; Ouden, H. den; Carlier, I.V.E.; Vliet, I.M. van; Zitman, F.G. & Stiggelbout, A.M. (2015), Dutch Translation and Psychometric Testing of the 9-Item Shared Decision Making Questionnaire (SDM-Q-9) and Shared Decision Making Questionnaire-Physician Version (SDM-Q-Doc) in Primary and Secondary Care, PLoS ONE 10(7).
- Beenakker, J.W.M.; Shamonin, D.P.; Webb, A.G.; Stoel, B.C. & Luyten, G.P.M. (2015), Improved 3D retinal shape models with high-field MRI, Investigative Ophthalmology & Visual Science 56(7).
- Dogrusoz, M.; Kroes, W.G.M.; Duinen, S. van; Creutzberg, C.L.; Versluis, M.; Bleeker, J.C.; Marinkovic, M.; Luyten, G.P.M. & Jager, M.J. (2015), Irradiation enhances chromosomal aberrations in uveal melanoma, Investigative Ophthalmology & Visual Science 56(7).
- Gezgin, G.; Bronkhorst, I.H.G.; Essen, T.H. van; Pelt, S. van; Verdijk, R.M.; Velden, P.A. van der; Luyten, G.P.M.; Hall, T. van; Burg, S.H. van der & Jager, M.J. (2015), Loss of BAPI expression is associated with increased angiogenesis in uveal melanoma, Investigative Ophthalmology & Visual Science 56(7).
- State, M.; Beenakker, J.W.M.; Shamonin, D.P.; Mooren, M. van der; Stoel, B.C.; Webb, A.G.; Luyten, G.P.M. & Piers, P.A. (2015), Retinal shape assessment in young phakic eyes by a combined partial coherence interferometry - magnetic resonance imaging approach, Investigative Ophthalmology & Visual Science 56(7).
- Boon, C.J.F.; Dijk, E.H.C. van; Herpen, C.M.L. van; Marinkovic, M.; Amundson, D.; Luyten, G.P.M.; Jager, M.J.; Kapiteijn, E.H.W.; Keunen, J.E.E. & Adamus, G. (2015), Serous retinopathy associated with MEK inhibition (binimetinib) for metastatic cutaneous and uveal melanoma, Investigative Ophthalmology & Visual Science 56(7).
- Nielsen, M.; Dogrusoz, M.; Bleeker, J.C.; Kroes, W.G.; Asperen, C.A. van; Marinkovic, M.; Luyten, G.P.M. & Jager, M.J. (2015), The genetic basis of uveal melanoma, Journal Fran�ais D'Ophtalmologie 38(6): 516-521.
- Versluis, M.; Lange, M.J. de; Pelt, S.I. van; Ruivenkamp, C.A.L.; Kroes, W.G.M.; Cao, J.F.; Jager, M.J.; Luyten, G.P.M. & Velden, P.A. van der (2015), Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma, PLoS ONE 10(3).
- Beenakker, J.W.M.; Shamonin, D.P.; Webb, A.G.; Luyten, G.P.M. & Stoel, B.C. (2015), Automated Retinal Topographic Maps Measured With Magnetic Resonance Imaging, Investigative Ophthalmology & Visual Science 56(2): 1033-1039.
- Essen, T.H. van; Pelt, S.I. van; Versluis, M.; Bronkhorst, I.H.G.; Duinen, S.G. van; Marinkovic, M.; Kroes, W.G.M.; Ruivenkamp, C.A.L.; Shukla, S.; Klein, A. de; Kilic, E.; Harbour, J.W.; Luyten, G.P.M.; Velden, P.A. van der; Verdijk, R.M. & Jager, M.J. (2014), Prognostic parameters in uveal melanoma and their association with BAP1 expression, British Journal of Ophthalmology 98(12): 1738-1743.
- Bronkhorst, I.H.G.; Jehs, T.M.L.; Dijkgraaf, E.M.; Luyten, G.P.M.; Velden, P.A. van der; Burg, S.H. van der & Jager, M.J. (2014), Effect of Hypoxic Stress on Migration and Characteristics of Monocytes in Uveal Melanoma, JAMA Ophthalmology 132(5): 614-621.
- Roukens, A.H.; Kroep, J.R.; Marinkovic, M.; Nout, R.A.; Bovee, J.V.M.G.; Vasylenko, Y.; Gelderblom, H. & Lutyen, G.P.M. (2014), Primary Ewing sarcoma of the iris, Lancet 383(9913): 256-256.
- Beenakker, J.W.M.; Rijn, G.A. van; Luyten, G.P.M. & Webb, A.G. (2013), High-resolution MRI of uveal melanoma using a microcoil phased array at 7 T, NMR in Biomedicine 26(12): 1864-1869.
- Rijn, G.A. van; Snoek, C.; Joosse, M.; Saxena, R. & Luyten, G.P.M. (2013), Implantation of phakic intraocular lens in 3 patients with oculocutaneous albinism, Journal of Cataract and Refractive Surgery 39(10): 1604-1608.
- Bronkhorst, I.H.G.; Jehs, T.M.L.; Dijkgraaf, E.M.; Luyten, G.P.M.; Velden, P.A. van der; Burg, S.H. van der & Jager, M.J. (2013), Effect of hypoxic stress on induction and plasticity of tumor-induced immune cells in uveal melanoma, Acta Ophthalmologica 91.
- Pelt, S. van; Essen, T.H. van; Bronkhorst, I.H.G.; Versluis, M.; Luyten, G.P.M.; Hall, T. van; Elsen, P.J. van den; Velden, P.A. van & Jager, M.J. (2013), Gain of chromosome 6 status does not influence HLA-expression in uveal melanoma.
- Geus, S.J.R. de; Jager, M.J.; Luyten, G.P.M. & Dijkman, G. (2013), Shifting exudative age-related macular degeneration patients to ranibizumab after insufficient response to bevacizumab, Acta Ophthalmologica 91(5): E411-E413.
- Essen, T.H. van; Zijl, L. van; Sparks, S.J.; Chen, G.; Lin, C.C.; Lai, H.J.; Luyten, G.P.M.; Ghalbzouri, A.E.L. & Jager, M.J. (2013), Suitability of a fish scale-derived collagen matrix (FSCM) as artificial cornea, Acta Ophthalmologica 91.
- Essen, T.H. van; Lin, C.C.; Hussain, A.K.; Maas, S.; Lai, H.J.; Linnartz, H.; Berg, T.J.T.P. van den; Salvatori, D.C.F.; Luyten, G.P.M. & Jager, M.J. (2013), A Fish Scale-Derived Collagen Matrix as Artificial Cornea in Rats: Properties and Potential, Investigative Ophthalmology & Visual Science 54(5): 3224-3233.
- Vu, T.H.K.; Bronkhorst, I.H.G.; Versluis, M.; Marinkovic, M.; Duinen, S.G. van; Vrolijk, J.; Luyten, G.P.M. & Jager, M.J. (2013), Analysis of Inflammatory Cells in Uveal Melanoma after Prior Irradiation, Investigative Ophthalmology & Visual Science 54(1): 360-369.
- el Filali M, van der Velden PA, Luyten GP & Jager MJ (2012), Anti-angiogenic therapy in uveal melanoma., Developments in Ophthalmology 49: 117-36.
- Filali, M. el; Ly, L.V.; Luyten, G.P.M.; Versluis, M.; Grossniklaus, H.E.; Velden, P.A. van der & Jager, M.J. (2012), Bevacizumab and intraocular tumors: an intriguing paradox., Molecular Vision 18: 2454-67.
- Lange, J. de; Teunisse, A.F.A.S.; Verlaan-de Vries, M.; Lodder, K.; Lam, S.; Luyten, G.P.M.; Bernal, F.; Jager, M.J. & Jochemsen, A.G. (2012), High levels of Hdmx promote cell growth in a subset of uveal melanomas., American Journal of Cancer Research 2(5): 492-507.
- Razzaq, L.; Marinkovic, M.; Jager, M.J.; Bleeker, J.; Luyten, G.P.M. & Keizer, R.J.W. de (2012), Corneal endothelial cell density after ruthenium plaque radiation therapy for iris melanoma patients.
- Nagarkatti-Gude, N.; Bronkhorst, I.H.G.; Duinen, S.G. van; Luyten, G.P.M. & Jager, M.J. (2012), Cytokines and Chemokines in the Vitreous Fluid of Eyes with Uveal Melanoma, Investigative Ophthalmology & Visual Science 53(11): 6748-6755.
- Bronkhorst, I.H.G.; Vu, T.H.K.; Jordanova, E.S.; Luyten, G.P.M.; Burg, S.H. van der & Jager, M.J. (2012), Different Subsets of Tumor-Infiltrating Lymphocytes Correlate with Macrophage Influx and Monosomy 3 in Uveal Melanoma, Investigative Ophthalmology & Visual Science 53(9): 5370-5378.
- Rijn, G.A. van; Mourik, J.E.M.; Teeuwisse, W.M.; Luyten, G.P.M. & Webb, A.G. (2012), Magnetic Resonance Compatibility of Intraocular Lenses Measured at 7 Tesla, Investigative Ophthalmology & Visual Science 53(7): 3449-3453.
- Essen, T.H. van; Bronkhorst, I.H.G.; Maat, W.; Verduyn, W.; Roelen, D.L.; Luyten, G.P.M. & Jager, M.J. (2012), A Comparison of HLA Genotype with Inflammation in Uveal Melanoma, Investigative Ophthalmology & Visual Science 53(6): 2640-2646.
- Vlaskamp M, de Wolff-Rouendaal D, Jansen PM & Luyten GP (2012), Concomitant choroidal melanoma and non-hodgkin lymphoma in two adult patients: case report., Case Reports in Ophthalmology 3(2): 209-13.
- Vries, F.R. de; Notting, I.C.; Marinkovic, M.; Schalij-Delfos, N.E. & Luyten, G.P.M. (2012), Complications due to bovine pericardium used to cover acrylic implants after enucleation and tubes of aqueous devices., Eye 26(2): 336.
- Muller, K.; Naus, N.; Nowak, P.J.C.M.; Schmitz, P.I.M.; Pan, C. de; Santen, C.A. van; Marijnissen, J.P.; Paridaens, D.A.; Levendag, P.C. & Luyten, G.P.M. (2012), Fractionated stereotactic radiotherapy for uveal melanoma, late clinical results, Radiotherapy and Oncology 102(2): 219-224.
- Razzaq L, Marinkovic M, Swart W, van Duinen SG, Keunen JE & Luyten GP (2012), Fuchs' adenoma of the choroid simulating a choroidal hemangioma., Case Reports in Ophthalmology 3(1): 83-6.
- Razzaq, L.; Semenova, E.A.; Marinkovic, M.; Keizer, R.J.W. de; Duinen, S.G. van & Luyten, G.P.M. (2011), Mesectodermal Suprauveal Iridociliary Leiomyoma: Transscleral Excision Without Postoperative Iris Defect, Archives of Ophthalmology -New Series- 129(12): 1635-1637.
- Kamar, S.; Vervaet, C.; Luyten, G.P.M. & Jager, M.J. (2011), Pancorneal contact lens with a toric edge: a new concept in keratoconus., European Journal of Ophthalmology 21(6): 685-90.
- Bronkhorst, I.H.G.; Maat, W.; Jordanova, E.S.; Kroes, W.G.M.; Schalij-Delfos, N.E.; Luyten, G.P.M. & Jager, M.J. (2011), Effect of Heterogeneous Distribution of Monosomy 3 on Prognosis in Uveal Melanoma, Archives of Pathology and Laboratory Medicine 135(8): 1042-1047.
- Bronkhorst, I.H.G.; Ly, L.V.; Jordanova, E.S.; Vrolijk, J.; Versluis, M.; Luyten, G.P.M. & Jager, M.J. (2011), Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival, Investigative Ophthalmology & Visual Science 52(2): 643-650.
- Razzaq, L.; Emmanouilidis-van der Spek, K.; Luyten, G.P.M. & Keizer, R.J.W. de (2011), Anterior segment imaging for iris melanocytic tumors., European Journal of Ophthalmology.
- Ly, L.V.; Bronkhorst, I.H.G.; Beelen, E. van; Vrolijk, J.; Taylor, A.W.; Versluis, M.; Luyten, G.P.M. & Jager, M.J. (2010), Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration, Investigative Ophthalmology & Visual Science 51(11): 5445-5451.
- Ly, L.V.; Sluijter, M.; Versluis, M.; Luyten, G.P.M.; Burg, S.H. van der; Melief, C.J.M.; Jager, M.J. & Hall, T. van (2010), Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm, Cancer Research 70(21): 8339-8346.
- Ly, L.V.; Baghat, A.; Versluis, M.; Jordanova, E.S.; Luyten, G.P.M.; Rooijen, N. van; Hall, T. van; Velden, P.A. van der & Jager, M.J. (2010), In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages, Journal of Immunology 185(6): 3481-3488.
- Akdag, F.; Hafezi, F.; Heule-Dieleman, H.A.G.; Bosch, W.A. van den; Luyten, G.P.M.; Tanghe, H.L.J. & Paridaens, D. (2010), Orbital metastases of breast cancer, Ophthalmologe 107(8): 728-732.
- Ly, L.V.; Odish, O.F.F.; Wolff-Rouendaal, D. de; Missotten, G.S.O.A.; Luyten, G.P.M. & Jager, M.J. (2010), Intravascular Presence of Tumor Cells as Prognostic Parameter in Uveal Melanoma: A 35-Year Survey, Investigative Ophthalmology & Visual Science 51(2): 658-665.
- Filali, M. el; Missotten, G.S.O.A.; Maat, W.; Ly, L.V.; Luyten, G.P.M.; Velden, P.A. van der & Jager, M.J. (2010), Regulation of VEGF-A in uveal melanoma, Investigative Ophthalmology & Visual Science.
- Ly L.V., Bronkhorst I.H.G., Beelen E. van, Taylor A.W., Versluis M., Luyten G.P.M., Claas F.H.J. & Jager M.J. (2010), Significance of inflammatory cytokines in eyes with uveal melanoma and relation with the presence of macrophage subtypes, Investigative Ophthalmology & Visual Science.
- El Filali M, Missotten GS, Maat W, Ly LV, Luyten GP, Van der Velden P & Jager MJ (2009), Regulation of VEGF-A in uveal melanoma.
- Maat W, el Filali M, Dirks-Mulder A, Luyten GPM, Gruis NA, Desjardins L, Boender P, Jager MJ & van der Velden PA (2009), Episodic Src activation in uveal melanoma revealed by kinase activity profiling, British Journal of Cancer 101(2): 312-319.
- Maat W, van der Slik AR, Verhoeven DHJ, Alizadeh BZ, Ly LV, Verduijn W, Luyten GPM, Mulder A, van Hall T & Koning F (2009), Evidence for Natural Killer Cell-Mediated Protection from Metastasis Formation in Uveal Melanoma Patients, Investigative Ophthalmology & Visual Science 50(6): 2888-2895.
- Muller K, Nowak PJCM, Naus N, de Pan C, van Santen CA, Levendag P & Luyten GPM (2009), LACRIMAL GLAND RADIOSENSITIVITY IN UVEAL MELANOMA PATIENTS, International Journal of Radiation Oncology - Biology - Physics 74(2): 497-502.
- Dick HB, Budo C, Malecaze F, Guell JL, Marinho AAP, Nuijts RMMA, Luyten GPM, Menezo JL & Kohnen T (2009), Foldable Artiflex Phakic Intraocular Lens for the Correction of Myopia Two-Year Follow-up Results of a Prospective European Multicenter Study, Ophthalmology: Journal of The American Academy of Ophthalmology 116(4): 671-677.
- Mensink HW, Vaarwater J, Kilic E, Naus NC, Mooy N, Luyten G, Bruggenwirth HT, Paridaens D & de Klein A (2009), Chromosome 3 Intratumor Heterogeneity in Uveal Melanoma, Investigative Ophthalmology & Visual Science 50(2): 500-504.
- Filali MKE, Kilic E, Melis M, de Klein A, de Jong M & Luyten GPM (2008), Expression of the SST receptor 2 in uveal melanoma is not a prognostic marker, Graefe's Archive for Clinical and Experimental Ophthalmology 246(11).
- Kilic E, Bruggenwirth HT, Meier M, Naus NC, Beverloo HB, Meijerink JR, Luyten GP & de Klein A (2008), Increased expression of p73 Delta ex2 transcript in uveal melanoma with loss of chromosome 1p, Melanoma Research 18(3).
- Maat W, Beiboer SHW, Jager MJ, Luyten GPM, Gruis NA & van der Velden PA (2008), Epigenetic regulation identifies RASEF as a tumor-suppressor gene in uveal melanoma, Investigative Ophthalmology & Visual Science 49(4).
- Saxena R, Boekhoorn SS, Mulder PGH, Noordzij B, van Rij G & Luyten GPM (2008), Long-term follow-up of endothelial cell change after artisan phakic intraocular lens implantation, Ophthalmology: Journal of The American Academy of Ophthalmology 115(4).
- Kilic E, Stijnen T & Luyten GPM (2008), Preenucleation radiotherapy, uveal melanoma, and competing risks - In reply, Archives of Ophthalmology -New Series- 126(4).
- Maat W, Missotten GS, Luyten GPM & de Keizer RJW (2008), Retained intraocular foreign body masquerading as malignant melanoma of the iris, Graefe's Archive for Clinical and Experimental Ophthalmology 246(4).
- Maat W, Kilic E, Luyten GPM, De Klein A, Jager MJ, Gruis NA & Van der Velden PA (2008), Pyrophosphorolysis detects B-RAF mutations in primary uveal melanoma, Investigative Ophthalmology & Visual Science 49(1).
- van Gils W, Mensink HW, Kilic E, Vaarwater J, Verbiest MM, Paridaens D, Luyten GP, de Klein A & Bruggenwirth HT (2007), Expression of APITD1 is not related to copy number changes of chromosomal region 1p36 or the prognosis of uveal melanoma, Investigative Ophthalmology & Visual Science 48(11).
- Hes FJ, van der Luijt RB, Janssen ALW, Zewald RA, de Jong GJ, Lenders JW, Links TP, Luyten GPM, Sijmons RH, Eussen HJ, Halley DJJ, Lips CJM, Pearson PL, van den Ouweland AMW & Majoor-Krakauer DF (2007), Frequency of Von Hippel-Lindau germline mutations in classic and non-classic Von Hippel-Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification, Clinical Genetics 72(2).
- Zuidervaart W & Luyten GPM (2005), A retrospective analysis of five intra-ocular lenses and the predictive value of six different intra-ocular lens power calculation formulas, Ophthalmologica 219(6).
- Lid Raad van Toezicht
- lid Raad van Toezicht
- lid Raad van Toezicht